• 130 Citations
  • 7 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


  • 2013.01  PhD, International Business, National Taiwan University.
  • 2004.06  M.S., Institute of Technology Management, National Tsing Hua University.
  • 2002.06  B.S., School of Pharmacy, Taipei Medical University.


  • 2020.08- Vice Dean, Data Science, Taipei Medical University
  • 2020.02- Assistant Professor, Ph.D. Program in Biotech and Healthcare Management, College of Management, Taipei Medical University, Taipei, Taiwan.
  • 2014.08-2020.01 Assistant Professor, School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • 2013.09-2014.06 Postdoctoral Fellow, Department of Population Medicine, Harvard Medical School, Harvard University, Boston, USA.

Research Interests

  • Big Data Analysis and Research Methodology
  • International Biotech and Healthcare Management (Industry and Market Analysis, Product Value Assessment and Health Policy Management)

Fingerprint Dive into the research topics where Jason C. Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

  • 130 Citations
  • 7 h-Index
  • 25 Article

Comparative effectiveness and costeffectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan

Yang, S. C., Lai, W. W., Hsu, J. C., Su, W. C. & Wang, J. D., Apr 2020, In : PLoS ONE. 15, 4, e0231413.

Research output: Contribution to journalArticle

Open Access
  • Health inequality: A longitudinal study on geographic variations in lung cancer incidence and mortality in Taiwan

    Hsu, J. C., Tseng, Y. C., Chang, S. M., Lee, Y. C., Lin, P. C. & Chu, H. J., Jun 17 2020, In : BMC Public Health. 20, 1, 951.

    Research output: Contribution to journalArticle

    Open Access
  • Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: An interrupted time series study

    Hsu, J. C., Wei, C. F., Yang, S. C., Lin, P. C., Lee, Y. C. & Lu, C. Y., May 10 2020, In : BMJ Open. 10, 5, e033427.

    Research output: Contribution to journalArticle

    Open Access
  • Budget impact analysis of osteoporosis medications for primary prevention of fractures in Taiwan

    Wu, K. L., Wu, C. H., Chang, Y. F., Lin, Y. T. & Hsu, J. C., Jan 1 2019, (Accepted/In press) In : Journal of Bone and Mineral Metabolism.

    Research output: Contribution to journalArticle

  • Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatment

    Hsu, J. C., Lin, J. Y., Lin, P. C. & Lee, Y. C., Jan 1 2019, In : PLoS ONE. 14, 12, e0225938.

    Research output: Contribution to journalArticle

    Open Access